The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Circulating Tumor DNA Test Kit Market Research Report 2025
Synopsis
During the process of tumor cell proliferation and constant cell cycle transformation, tumor DNA fragments can enter the bloodstream. These tumor DNA fragments in the bloodstream are tumor circulating DNA, or ctDNA for short.
Global Circulating Tumor DNA Test Kit market is projected to reach US$ million in 2030, increasing from US$ million in 2023, with the CAGR of % during the period of 2024 to 2030.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2019-2023) and forecast calculation (2024-2030), aims to help readers to get a comprehensive understanding of global Circulating Tumor DNA Test Kit market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Grail, Inc.
Guardant Health, Inc.
Biodesix, Inc.
Exosome Diagnostics
Freenome Inc.
LungLife AI, Inc.
Inivata Ltd.
Personal Genome Diagnostics, Inc.
CellMax Life
Segment by Type
Blood Cancer
Solid Tumor
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Circulating Tumor DNA Test Kit report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
During the process of tumor cell proliferation and constant cell cycle transformation, tumor DNA fragments can enter the bloodstream. These tumor DNA fragments in the bloodstream are tumor circulating DNA, or ctDNA for short.
Global Circulating Tumor DNA Test Kit market is projected to reach US$ million in 2030, increasing from US$ million in 2023, with the CAGR of % during the period of 2024 to 2030.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2019-2023) and forecast calculation (2024-2030), aims to help readers to get a comprehensive understanding of global Circulating Tumor DNA Test Kit market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Grail, Inc.
Guardant Health, Inc.
Biodesix, Inc.
Exosome Diagnostics
Freenome Inc.
LungLife AI, Inc.
Inivata Ltd.
Personal Genome Diagnostics, Inc.
CellMax Life
Segment by Type
Blood Cancer
Solid Tumor
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Circulating Tumor DNA Test Kit report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Circulating Tumor DNA Test Kit Market Overview
1.1 Product Overview and Scope of Circulating Tumor DNA Test Kit
1.2 Circulating Tumor DNA Test Kit Segment by Type
1.2.1 Global Circulating Tumor DNA Test Kit Market Value Comparison by Type (2024-2030)
1.2.2 Blood Cancer
1.2.3 Solid Tumor
1.3 Circulating Tumor DNA Test Kit Segment by Application
1.3.1 Global Circulating Tumor DNA Test Kit Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Circulating Tumor DNA Test Kit Market Size Estimates and Forecasts
1.4.1 Global Circulating Tumor DNA Test Kit Revenue 2019-2030
1.4.2 Global Circulating Tumor DNA Test Kit Sales 2019-2030
1.4.3 Global Circulating Tumor DNA Test Kit Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Circulating Tumor DNA Test Kit Market Competition by Manufacturers
2.1 Global Circulating Tumor DNA Test Kit Sales Market Share by Manufacturers (2019-2024)
2.2 Global Circulating Tumor DNA Test Kit Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Circulating Tumor DNA Test Kit Average Price by Manufacturers (2019-2024)
2.4 Global Circulating Tumor DNA Test Kit Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Circulating Tumor DNA Test Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Circulating Tumor DNA Test Kit, Product Type & Application
2.7 Circulating Tumor DNA Test Kit Market Competitive Situation and Trends
2.7.1 Circulating Tumor DNA Test Kit Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Circulating Tumor DNA Test Kit Players Market Share by Revenue
2.7.3 Global Circulating Tumor DNA Test Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Circulating Tumor DNA Test Kit Retrospective Market Scenario by Region
3.1 Global Circulating Tumor DNA Test Kit Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Circulating Tumor DNA Test Kit Global Circulating Tumor DNA Test Kit Sales by Region: 2019-2030
3.2.1 Global Circulating Tumor DNA Test Kit Sales by Region: 2019-2024
3.2.2 Global Circulating Tumor DNA Test Kit Sales by Region: 2025-2030
3.3 Global Circulating Tumor DNA Test Kit Global Circulating Tumor DNA Test Kit Revenue by Region: 2019-2030
3.3.1 Global Circulating Tumor DNA Test Kit Revenue by Region: 2019-2024
3.3.2 Global Circulating Tumor DNA Test Kit Revenue by Region: 2025-2030
3.4 North America Circulating Tumor DNA Test Kit Market Facts & Figures by Country
3.4.1 North America Circulating Tumor DNA Test Kit Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Circulating Tumor DNA Test Kit Sales by Country (2019-2030)
3.4.3 North America Circulating Tumor DNA Test Kit Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Circulating Tumor DNA Test Kit Market Facts & Figures by Country
3.5.1 Europe Circulating Tumor DNA Test Kit Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Circulating Tumor DNA Test Kit Sales by Country (2019-2030)
3.5.3 Europe Circulating Tumor DNA Test Kit Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Circulating Tumor DNA Test Kit Market Facts & Figures by Country
3.6.1 Asia Pacific Circulating Tumor DNA Test Kit Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Circulating Tumor DNA Test Kit Sales by Country (2019-2030)
3.6.3 Asia Pacific Circulating Tumor DNA Test Kit Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Circulating Tumor DNA Test Kit Market Facts & Figures by Country
3.7.1 Latin America Circulating Tumor DNA Test Kit Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Circulating Tumor DNA Test Kit Sales by Country (2019-2030)
3.7.3 Latin America Circulating Tumor DNA Test Kit Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Circulating Tumor DNA Test Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Circulating Tumor DNA Test Kit Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Circulating Tumor DNA Test Kit Sales by Country (2019-2030)
3.8.3 Middle East and Africa Circulating Tumor DNA Test Kit Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Circulating Tumor DNA Test Kit Sales by Type (2019-2030)
4.1.1 Global Circulating Tumor DNA Test Kit Sales by Type (2019-2024)
4.1.2 Global Circulating Tumor DNA Test Kit Sales by Type (2025-2030)
4.1.3 Global Circulating Tumor DNA Test Kit Sales Market Share by Type (2019-2030)
4.2 Global Circulating Tumor DNA Test Kit Revenue by Type (2019-2030)
4.2.1 Global Circulating Tumor DNA Test Kit Revenue by Type (2019-2024)
4.2.2 Global Circulating Tumor DNA Test Kit Revenue by Type (2025-2030)
4.2.3 Global Circulating Tumor DNA Test Kit Revenue Market Share by Type (2019-2030)
4.3 Global Circulating Tumor DNA Test Kit Price by Type (2019-2030)
5 Segment by Application
5.1 Global Circulating Tumor DNA Test Kit Sales by Application (2019-2030)
5.1.1 Global Circulating Tumor DNA Test Kit Sales by Application (2019-2024)
5.1.2 Global Circulating Tumor DNA Test Kit Sales by Application (2025-2030)
5.1.3 Global Circulating Tumor DNA Test Kit Sales Market Share by Application (2019-2030)
5.2 Global Circulating Tumor DNA Test Kit Revenue by Application (2019-2030)
5.2.1 Global Circulating Tumor DNA Test Kit Revenue by Application (2019-2024)
5.2.2 Global Circulating Tumor DNA Test Kit Revenue by Application (2025-2030)
5.2.3 Global Circulating Tumor DNA Test Kit Revenue Market Share by Application (2019-2030)
5.3 Global Circulating Tumor DNA Test Kit Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Grail, Inc.
6.1.1 Grail, Inc. Corporation Information
6.1.2 Grail, Inc. Description and Business Overview
6.1.3 Grail, Inc. Circulating Tumor DNA Test Kit Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Grail, Inc. Circulating Tumor DNA Test Kit Product Portfolio
6.1.5 Grail, Inc. Recent Developments/Updates
6.2 Guardant Health, Inc.
6.2.1 Guardant Health, Inc. Corporation Information
6.2.2 Guardant Health, Inc. Description and Business Overview
6.2.3 Guardant Health, Inc. Circulating Tumor DNA Test Kit Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Guardant Health, Inc. Circulating Tumor DNA Test Kit Product Portfolio
6.2.5 Guardant Health, Inc. Recent Developments/Updates
6.3 Biodesix, Inc.
6.3.1 Biodesix, Inc. Corporation Information
6.3.2 Biodesix, Inc. Description and Business Overview
6.3.3 Biodesix, Inc. Circulating Tumor DNA Test Kit Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Biodesix, Inc. Circulating Tumor DNA Test Kit Product Portfolio
6.3.5 Biodesix, Inc. Recent Developments/Updates
6.4 Exosome Diagnostics
6.4.1 Exosome Diagnostics Corporation Information
6.4.2 Exosome Diagnostics Description and Business Overview
6.4.3 Exosome Diagnostics Circulating Tumor DNA Test Kit Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Exosome Diagnostics Circulating Tumor DNA Test Kit Product Portfolio
6.4.5 Exosome Diagnostics Recent Developments/Updates
6.5 Freenome Inc.
6.5.1 Freenome Inc. Corporation Information
6.5.2 Freenome Inc. Description and Business Overview
6.5.3 Freenome Inc. Circulating Tumor DNA Test Kit Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Freenome Inc. Circulating Tumor DNA Test Kit Product Portfolio
6.5.5 Freenome Inc. Recent Developments/Updates
6.6 LungLife AI, Inc.
6.6.1 LungLife AI, Inc. Corporation Information
6.6.2 LungLife AI, Inc. Description and Business Overview
6.6.3 LungLife AI, Inc. Circulating Tumor DNA Test Kit Sales, Revenue and Gross Margin (2019-2024)
6.6.4 LungLife AI, Inc. Circulating Tumor DNA Test Kit Product Portfolio
6.6.5 LungLife AI, Inc. Recent Developments/Updates
6.7 Inivata Ltd.
6.6.1 Inivata Ltd. Corporation Information
6.6.2 Inivata Ltd. Description and Business Overview
6.6.3 Inivata Ltd. Circulating Tumor DNA Test Kit Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Inivata Ltd. Circulating Tumor DNA Test Kit Product Portfolio
6.7.5 Inivata Ltd. Recent Developments/Updates
6.8 Personal Genome Diagnostics, Inc.
6.8.1 Personal Genome Diagnostics, Inc. Corporation Information
6.8.2 Personal Genome Diagnostics, Inc. Description and Business Overview
6.8.3 Personal Genome Diagnostics, Inc. Circulating Tumor DNA Test Kit Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Personal Genome Diagnostics, Inc. Circulating Tumor DNA Test Kit Product Portfolio
6.8.5 Personal Genome Diagnostics, Inc. Recent Developments/Updates
6.9 CellMax Life
6.9.1 CellMax Life Corporation Information
6.9.2 CellMax Life Description and Business Overview
6.9.3 CellMax Life Circulating Tumor DNA Test Kit Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CellMax Life Circulating Tumor DNA Test Kit Product Portfolio
6.9.5 CellMax Life Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Circulating Tumor DNA Test Kit Industry Chain Analysis
7.2 Circulating Tumor DNA Test Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Circulating Tumor DNA Test Kit Production Mode & Process
7.4 Circulating Tumor DNA Test Kit Sales and Marketing
7.4.1 Circulating Tumor DNA Test Kit Sales Channels
7.4.2 Circulating Tumor DNA Test Kit Distributors
7.5 Circulating Tumor DNA Test Kit Customers
8 Circulating Tumor DNA Test Kit Market Dynamics
8.1 Circulating Tumor DNA Test Kit Industry Trends
8.2 Circulating Tumor DNA Test Kit Market Drivers
8.3 Circulating Tumor DNA Test Kit Market Challenges
8.4 Circulating Tumor DNA Test Kit Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
